Hosted on MSN26d
Improved lipid-polymer nanoparticle could advance inhalable mRNA medications and vaccinesResearchers outline their improved lipid-polymer nanoparticle for holding mRNA that is stable when nebulized and successfully delivers aerosols (liquid droplets) into mice's lungs. mRNA medicines ...
BERWYN, PA — Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) has announced its plans to explore utilizing Molecular Envelope ...
Improved lipid-polymer nanoparticle could advance inhalable mRNA medications and vaccines Nov 13, 2024 Precision pulmonary medicine: Engineers target lung disease with lipid nanoparticles ...
Among existing delivery methods, lipid nanoparticles (LNPs ... the POSTECH research team explored the biodegradable polymer Poly β-amino ester (PBAE) as an alternative. PBAE has already been ...
Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) ("Virpax" or the "Company"), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central ...
Nanomedicine. 2014;9(1):105-120. SNALP & its Application. SNALP is constructed by three basic lipids: an ionizable cationic lipid (1,2-dilinoleyloxy-3-dimethylaminopropane), a neutral helper lipid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results